Purification and characterization of lipoprotein lipase and hepatic triglyceride lipase from human postheparin plasma: production of monospecific antibody to the individual lipase.
Lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) were purified to homogeneity from human postheparin plasma. Molecular, catalytic and immunological properties of the purified enzymes were investigated. The native molecular weights of LPL and HTGL were 67,200 and 65,500, respectively, by gel chromatography. The subunit molecular weights of LPL and HTGL were 60,600 and 64,600, respectively, suggesting that these enzymes are catalytically active in a monomeric form. In addition, the purified LPL and HTGL each gave a single protein band when they were detected as glycoproteins with a probe of concanavalin A. The purified enzyme preparations were free of detectable antithrombin III by Western blot analysis. Catalytic properties of the purified enzymes were examined using triolein-gum arabic emulsion and triolein particles stabilized with phospholipid monolayer as substrates. LPL catalyzed the complete hydrolysis of triolein to free oleate and monooleate in the presence of apolipoprotein C-II. Apparent Km values for triolein and apolipoprotein C-II were 1.0 mM and 0.6 microM, and Vmax was 40.7 mmol/h per mg. HTGL hydrolyzed triolein substrate at a rate much slower than LPL, and produced mainly free oleate with little monooleate. Apparent Km and Vmax values were 2.5 mM and 16.1 mmol/h per mg, respectively. Polyclonal antibodies were developed against the purified LPL and HTGL. The purity and specificity of these antisera were ascertained by immunotitration, Ouchterlony double diffusion and Western blot analyses. The anti-human LPL and anti-human HTGL antiserum specifically reacted with the corresponding either native or denaturated enzyme, indicating that two enzymes were immunologically distinct. We developed an assay system for LPL and HTGL in human PHP by selective immunoprecipitation of each enzyme with the corresponding antiserum.
Ikeda
Y
Y
Department of Etiology and Pathophysiology, National Cardiovascular Center Research Institute, Osaka, Japan.
Takagi
A
A
Yamamoto
A
A
D000990:Antithrombin III / Q000032:analysis; D015153:Blotting, Western; D002845:Chromatography; D003902:Detergents; D004591:Electrophoresis, Polyacrylamide Gel; D006493:Heparin; D006801:Humans; D007158:Immunologic Techniques; D007700:Kinetics; D008049:Lipase / Q000097:blood* / Q000276:immunology; D008071:Lipoprotein Lipase / Q000097:blood* / Q000276:immunology; D008099:Liver / Q000201:enzymology; D008970:Molecular Weight; D010949:Plasma / Q000201:enzymology
D003902:Detergents; D000990:Antithrombin III; D006493:Heparin; D008049:Lipase; D008071:Lipoprotein Lipase